Kazia Therapeutics Ret. a saját tőke
Mi az Kazia Therapeutics Ret. a saját tőke?
A Ret. a saját tőke az Kazia Therapeutics Limited - -87.27%
Mi a Ret. a saját tőke meghatározása?
A saját tőke megtérülése egy vállalkozás nyereségességének mértéke a részvényes saját tőkéjének könyv szerinti értékéhez viszonyítva. Ezt úgy számítják ki, hogy a pénzügyi év nettó eredményét a teljes részvényes tőkével osztják el.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. a saját tőke a Health Care szektor a ASX-on cégekben a Kazia Therapeutics -hoz képest
Mit csinál Kazia Therapeutics?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
ret. a saját tőke -hoz hasonló cégek Kazia Therapeutics
- Unum Therapeutics nak Ret. a saját tőke -87.78% van
- Euro Manganese nak Ret. a saját tőke -87.60% van
- Velocity Property nak Ret. a saját tőke -87.57% van
- EQ nak Ret. a saját tőke -87.47% van
- DynaCERT nak Ret. a saját tőke -87.37% van
- Golden Wheel Tiandi nak Ret. a saját tőke -87.37% van
- Kazia Therapeutics nak Ret. a saját tőke -87.27% van
- China Properties nak Ret. a saját tőke -87.22% van
- Canna 8 Investment Trust nak Ret. a saját tőke -87.11% van
- Strongbridge Biopharma plc nak Ret. a saját tőke -87.06% van
- Nio Inc Nio American Depositary nak Ret. a saját tőke -87.02% van
- Copper Lake Resources nak Ret. a saját tőke -86.95% van
- Elegance Optical International nak Ret. a saját tőke -86.91% van